Harpoon Therapeutics Inc
F:5HT

Watchlist Manager
Harpoon Therapeutics Inc Logo
Harpoon Therapeutics Inc
F:5HT
Watchlist
Price: 8.15 EUR Market Closed
Market Cap: 208.2m EUR

Net Margin
Harpoon Therapeutics Inc

-81.7%
Current
-300%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-81.7%
=
Net Income
-30.5m
/
Revenue
37.3m

Net Margin Across Competitors

No Stocks Found

Harpoon Therapeutics Inc
Glance View

Market Cap
208.2m EUR
Industry
Biotechnology

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. The company is headquartered in South San Francisco, California and currently employs 99 full-time employees. The company went IPO on 2019-02-08. The firm is engaged in the developing a T cell engager that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The company is developing a pipeline of T cell engagers using its TriTACs, focused on the treatment of solid tumors and hematologic malignancies. The company has also nominated its clinical candidate using its ProTriTAC platform, a prodrug version of its TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s TriTAC product candidates include HPN328, HPN217 and HPN536. The Company’s ProTriTAC product candidate include HPN601. T cell engagers are engineered proteins that direct a patient’s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells.

5HT Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-81.7%
=
Net Income
-30.5m
/
Revenue
37.3m
What is the Net Margin of Harpoon Therapeutics Inc?

Based on Harpoon Therapeutics Inc's most recent financial statements, the company has Net Margin of -81.7%.

Back to Top